Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | |
| Operating Expenses | 9,969 | 18,795 |
| Operating Income | -9,969 | -18,795 |
| Other Income | 157 | 291 |
| Pre-tax Income | -9,812 | -18,504 |
| Net Income Continuous | -9,812 | -18,504 |
| Net Income | $-9,812 | $-18,504 |
| EPS Basic Total Ops | -1.22 | -2.75 |
| EPS Basic Continuous Ops | -1.22 | -2.75 |
| EPS Diluted Total Ops | -1.22 | -2.75 |
| EPS Diluted Continuous Ops | -1.22 | -2.75 |
| EBITDA(a) | $-9,771 | $-14,741 |